DuraGraft
Commercial- Indications
- Coronary Artery Bypass Graft Surgery, Peripheral Bypass Surgery
Company intelligence / Profile preview
Somahlution
Jupiter, Florida, United Statesprnewswire.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
DuraGraft has demonstrated efficacy in protecting vascular graft integrity during bypass surgeries leading to reduced rates of myocardial infarction, repeat revascularization procedures, and other major adverse cardiac events associated with graft failure[3][5][7]. It is currently commercially available in Europe while US regulatory approval processes are ongoing under new ownership[5].
- Therapeutic areas
- Cardiovascular
- Modalities
- Medical device/preservation solution (DuraGraft)Clinical research services supporting vascular grafting procedures
- Industry
- Surgical Medical Devices
02
Drug pipeline
1 asset03
Partnerships
Distribution agreement with Marizyme for South America & Mexicomanufacturing agreement with BioLife Solutions previously
Beyond the preview
Go deeper on Somahlution.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Somahlution.